6 results on '"Pierre-Etienne Theveniaud"'
Number of results to display per page
Search Results
2. Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients
- Author
-
Rocco Domenico Alfonso Bellantone, Rasa Zarnegar, Brendan M. Finnerty, Phi-Linh Nguyen-Thi, Thomas J. Fahey, Wessel M. C. M. Vorselaars, Inne H.M. Borel Rinkes, Laurent Bresler, Pierre-Etienne Theveniaud, Laurent Brunaud, Myriam Boutami, Marco Raffaelli, Menno R. Vriens, Celestino Pio Lombardi, and Eric Mirallié
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Settore MED/18 - CHIRURGIA GENERALE ,Adrenal Gland Neoplasms ,Hemodynamics ,Pheochromocytoma ,030230 surgery ,Coronary artery disease ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Risk Factors ,medicine ,Humans ,Aged ,Retrospective Studies ,Past medical history ,business.industry ,Incidence (epidemiology) ,Adrenalectomy ,adrenalectomy ,Perioperative ,Middle Aged ,medicine.disease ,Surgery ,Treatment Outcome ,Blood pressure ,030220 oncology & carcinogenesis ,Anesthesia ,Female ,Laparoscopy ,business ,Abdominal surgery - Abstract
Since the 1950s, preoperative medical preparation has been widely applied in patients with pheochromocytoma to improve intraoperative hemodynamic instability and postoperative complications. However, advancements in preoperative imaging, laparoscopic surgical techniques, and anesthesia have considerably improved management in patients with pheochromocytoma. In consequence, there is no validated consensus on current predictive factors for postoperative morbidity. The aim of this study was to determine perioperative factors which are predictive for postoperative morbidity in patients undergoing laparoscopic adrenalectomy for pheochromocytoma. It is a retrospective analysis of prospectively maintained databases in five medical centers from 2002 to 2013. Inclusion criteria were consecutive patients who underwent non-converted laparoscopic unilateral total adrenalectomy for pheochromocytoma. Two-hundred and twenty-five patients were included. All-cause and cardiovascular postoperative morbidity rates were 16 % (n = 36) and 4.8 % (n = 11), respectively. Preinduction blood pressure normalization after preoperative medical preparation had no impact on postoperative morbidity. However, past medical history of coronary artery disease (OR [CI95 %] = 3.39; [1.317–8.727]) and incidence of intraoperative hemodynamic instability episodes (both SBP ≥ 160 mmHg and MAP
- Published
- 2016
3. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population
- Author
-
Laurent Salomon, Lionel Badet, Georges Karam, Jacques Tostain, Pierre Bigot, Nathalie Rioux-Leclercq, Sébastien Barbet, Jean-Etienne Terrier, Bernard Escudier, Michel Soulié, Hicham Elkentaoui, Abdel-Rahmène Azzouzi, Fabrice Dugardin, Yann Neuzillet, Jean-Christophe Bernhard, Jacques Hubert, Aurélien Descazeaux, Karim Fehri, Nicolas Brichart, Philippe Paparel, J.M. Boutin, Laurent Guy, Baptiste Tisserand, Arnaud Mejean, Ismaël Galliot, Marc-Olivier Timsit, Laurence Bastien, Jérôme Rigaud, Antoine Valeri, Jacques Petit, Laurent Zini, Benoit Barrou, Christian Pfister, Xavier Tillou, Franck Bruyère, Fabien Saint, Herve Lang, Jean-Jacques Patard, Marie-Dominique Azemar, Denis Chautard, Julien Branchereau, Hervé Wallerand, Pascal Rischmann, Laura Poissonnier, Charles Deruelle, Lucille Martin, Laurence Albiges, Jacques Irani, Arnauld Villers, Thierry Lebret, Hervé Baumert, François Kleinclauss, Nicolas Terrier, Jean-Alexandre Long, Pierre-Etienne Theveniaud, M. Gigante, Frédéric Staerman, Jean-Marie Ferriere, Romain Mathieu, Morgan Rouprêt, F. Sallusto, Benoit Feuillu, Service d'urologie, Hôpital Foch [Suresnes], CHU Amiens-Picardie, Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Hôpital Pontchaillou-CHU Pontchaillou [Rennes], CHU Grenoble-Hôpital Michallon, Service d'urologie-andrologie, CHU Saint-Etienne-Université Jean Monnet [Saint-Étienne] ( UJM ) -Hôpital nord, Service d'urologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] ( CHLS ), Hospices Civils de Lyon ( HCL ) -Hospices Civils de Lyon ( HCL ), Hôpital Saint-Joseph, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy ( IGR ), CHU Strasbourg, Service d'anatomie et cytologie pathologiques [Rennes], Université d'Angers ( UA ) -CHU Angers, Service d'urologie, andrologie et transplantation rénale, Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Institut Mondor de recherche biomédicale ( IMRB ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris-Est Créteil Val-de-Marne - Paris 12 ( UPEC UP12 ), Service d'urologie [Tours], Hôpital Bretonneau-CHRU Tours, Hôtel-Dieu, Service d'Urologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy ( CHRU Nancy ), Hôpital Huriez-Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), Service de Chirurgie urologique et andrologie [CHU Limoges], CHU Limoges, Service d'urologie et transplantation rénales [CHU Pitié-Salpétrière], Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Pitié-Salpêtrière [APHP], Service de Néphrologie et Urologie, Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Hôpital Saint-Jacques, Service d'urologie [Rouen], CHU Rouen-Université de Rouen Normandie ( UNIROUEN ), Normandie Université ( NU ) -Normandie Université ( NU ), Université de Reims Champagne-Ardenne ( URCA ), Centre hospitalier universitaire de Poitiers ( CHU Poitiers ) -Hôpital La Milétrie, Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Descartes - Paris 5 ( UPD5 ) -CHU Necker - Enfants Malades [AP-HP], Service d'Urologie - Transplantation Rénale - Andrologie, CHU Toulouse [Toulouse]-Hôpital de Rangueil, CHU Toulouse [Toulouse], CHU Clermont-Ferrand-Hôpital Gabriel Montpied, Université de Brest ( UBO ) -Centre Hospitalier Régional Universitaire de Brest ( CHRU Brest ), Service d'urologie [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 ( UPEC UP12 ), Université Paris-Sud - Paris 11 ( UP11 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Bicêtre, members of the Comité de Transplantation de l'Association Française d'Urologie, the Comité de Cancérologie de l'Association Française d'Urologie, Service d'urologie [Rennes], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], CHU Saint-Etienne-Université Jean Monnet [Saint-Étienne] (UJM)-Hôpital nord, Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Institut Gustave Roussy (IGR), Université d'Angers (UA)-Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Institut Mondor de recherche biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Bretonneau-Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Hôpital Huriez-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service d'urologie et transplantation rénales [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)-Hôpital Saint-Jacques, CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Université de Reims Champagne-Ardenne (URCA), Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Hôpital La Milétrie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Bicêtre-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11), Service d'urologie [Rennes] = Urology [Rennes], Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Service d'anatomie et cytologie pathologiques [Rennes] = Anatomy and Cytopathology [Rennes], CHU Pontchaillou [Rennes], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau, Service d'Urologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Hôpital Saint-Jacques, CHU Clermont-Ferrand-CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, De Villemeur, Hervé, CHU Saint-Etienne-Université Jean Monnet - Saint-Étienne (UJM)-Hôpital nord, Département d'Urologie-Andrologie et Transplantation Rénale [CHU Toulouse], Pôle Urologie - Néphrologie - Dialyse - Transplantations - Brûlés - Chirurgie plastique - Explorations fonctionnelles et physiologiques [CHU Toulouse], and Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
- Subjects
Male ,[ SDV.MHEP.UN ] Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology ,MESH: Chi-Square Distribution ,Time Factors ,MESH : Retrospective Studies ,030232 urology & nephrology ,MESH : Aged ,Kaplan-Meier Estimate ,MESH: Risk Assessment ,urologic and male genital diseases ,Gastroenterology ,[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology ,[ SDV.CAN ] Life Sciences [q-bio]/Cancer ,MESH: Proportional Hazards Models ,MESH : Carcinoma, Renal Cell ,0302 clinical medicine ,Renal cell carcinoma ,MESH: Risk Factors ,Risk Factors ,MESH : Female ,MESH : Neoplasm Staging ,MESH : Risk Assessment ,MESH: Treatment Outcome ,MESH: Aged ,education.field_of_study ,Univariate analysis ,MESH: Middle Aged ,MESH: Carcinoma, Renal Cell ,MESH: Neoplasm Staging ,Middle Aged ,MESH : Adult ,MESH : Survival Rate ,MESH : Risk Factors ,Kidney Neoplasms ,3. Good health ,Survival Rate ,Treatment Outcome ,MESH: Kidney Failure, Chronic ,030220 oncology & carcinogenesis ,Female ,France ,MESH : Time Factors ,Adult ,medicine.medical_specialty ,MESH: Survival Rate ,Urology ,MESH : Male ,Population ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,MESH : Treatment Outcome ,Risk Assessment ,MESH : Kidney Failure, Chronic ,End stage renal disease ,MESH : Kaplan-Meier Estimate ,03 medical and health sciences ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Internal medicine ,medicine ,Humans ,MESH : Middle Aged ,education ,MESH : France ,Survival rate ,Carcinoma, Renal Cell ,MESH: Kaplan-Meier Estimate ,Aged ,Neoplasm Staging ,Proportional Hazards Models ,Retrospective Studies ,MESH: Humans ,Chi-Square Distribution ,MESH : Chi-Square Distribution ,business.industry ,MESH: Time Factors ,MESH : Humans ,MESH: Adult ,MESH: Retrospective Studies ,medicine.disease ,MESH : Proportional Hazards Models ,[SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology ,MESH: Male ,MESH : Kidney Neoplasms ,Surgery ,Transplantation ,MESH: France ,Kidney Failure, Chronic ,MESH: Kidney Neoplasms ,business ,Kidney cancer ,MESH: Female ,Kidney disease - Abstract
International audience; BACKGROUND: Patients with end-stage renal disease (ESRD) are at risk of developing renal tumours. OBJECTIVE: Compare clinical, pathologic, and outcome features of renal cell carcinomas (RCCs) in ESRD patients and in patients from the general population. DESIGN, SETTING, AND PARTICIPANTS: Twenty-four French university departments of urology participated in this retrospective study. INTERVENTION: All patients were treated according to current European Association of Urology guidelines. MEASUREMENTS: Age, sex, symptoms, tumour staging and grading, histologic subtype, and outcome were recorded in a unique database. Categoric and continuous variables were compared by using chi-square and student statistical analyses. Cancer-specific survival (CSS) was assessed by Kaplan-Meier and Cox methods. RESULTS AND LIMITATIONS: The study included 1250 RCC patients: 303 with ESRD and 947 from the general population. In the ESRD patients, age at diagnosis was younger (55 ± 12 yr vs 62 ± 12 yr); mean tumour size was smaller (3.7 ± 2.6 cm vs 7.3 ± 3.8 cm); asymptomatic (87% vs 44%), low-grade (68% vs 42%), and papillary tumours were more frequent (37% vs 7%); and poor performance status (PS; 24% vs 37%) and advanced T categories (≥ 3) were more rare (10% vs 42%). Consistently, nodal invasion (3% vs 12%) and distant metastases (2% vs 15%) occurred less frequently in ESRD patients. After a median follow-up of 33 mo (range: 1-299 mo), 13 ESRD patients (4.3%), and 261 general population patients (27.6%) had died from cancer. In univariate analysis, histologic subtype, symptoms at diagnosis, poor PS, advanced TNM stage, high Fuhrman grade, large tumour size, and non-ESRD diagnosis context were adverse predictors for survival. However, only PS, TNM stage, and Fuhrman grade remained independent CSS predictors in multivariate analysis. The limitation of this study is related to the retrospective design. CONCLUSIONS: RCC arising in native kidneys of ESRD patients seems to exhibit many favourable clinical, pathologic, and outcome features compared with those diagnosed in patients from the general population.
- Published
- 2011
- Full Text
- View/download PDF
4. 2064 RENAL CELL CARCINOMAS ARISING IN NATIVE KIDNEYS OF DIALYZED AND TRANSPLANT PATIENTS: ARE THEY DIFFERENT ENTITIES?
- Author
-
Nicolas Brichart, Laurent Guy, Yann Neuzillet, Baptiste Tisserand, Jean-Alexandre Long, M. Gigante, Hicham Elkentaoui, Georges Karam, Pierre-Etienne Theveniaud, Jacques Petit, Laurent Zini, Abdel-Rahmène Azzouzi, Arnaud Mejean, Aurélien Descazeaux, Jean-Marie Ferriere, Antoine Valeri, Hervé Lang, Laurence Bastien, Fabien Saint, Denis Chautard, Julien Branchereau, Bernard Escudier, Hervé Baumert, Thierry Lebret, Benoit Barrou, Morgan Rouprêt, Jacques Hubert, Jean-Michel Boutin, Pascal Rischmann, Nathalie Rioux-Leclercq, Lucille Martin, Romain Mathieu, Sébastien Barbet, Jérôme Rigaud, Jean-Michel Correas, Jean-Etienne Terrier, Benoit Feuillu, Christian Pfister, Xavier Tillou, Federico Sallusto, Jean-Jacques Patard, Hervé Wallerand, Fabrice Dugardin, Philippe Paparel, Karim Fehri, François Kleinclauss, Nicolas Terrier, Charles Deruelle, Jacques Irani, Arnauld Villers, Jacques Tostain, Franck Bruyère, Marc-Olivier Timsit, Ismaël Galliot, Michel Soulié, Frédéric Staerman, Laurent Salomon, Lionel Badet, Pierre Bigot, Marie-Dominique Azemar, and Laura Poissonnier
- Subjects
Pathology ,medicine.medical_specialty ,medicine.anatomical_structure ,business.industry ,Urology ,Cell ,Medicine ,Transplant patient ,business - Published
- 2010
- Full Text
- View/download PDF
5. 505 CLINICO-PATHOLOGICAL AND OUTCOME FEATURES OF RENAL CELL CARCINOMAS IN PATIENTS WITH END STAGE RENAL DISEASE
- Author
-
Bernard Escudier, Arnaud Mejean, Nicolas Brichart, Jean-Michel Boutin, Yann Neuzillet, Pierre-Etienne Theveniaud, Nathalie Rioux-Leclercq, Georges Karam, Marc-Olivier Timsit, Sébastien Barbet, Jean-Alexandre Long, Jean-Etienne Terrier, Jean-Michel Correas, Fabrice Dugardin, Philippe Paparel, Lucille Martin, M. Gigante, Hervé Baumert, Laurence Bastien, Benoit Feuillu, Laurent Guy, Federico Sallusto, Aurélien Descazeaux, Morgan Rouprêt, Christian Pfister, Xavier Tillou, Hervé Wallerand, Thierry Lebret, Jean-Jacques Patard, Benoit Barrou, Jacques Tostain, François Kleinclauss, Nicolas Terrier, Michel Soulié, Pascal Rischmann, Abdel-Rahmène Azzouzi, Jérôme Rigaud, Hicham Elkentaoui, Jean-Marie Ferriere, Antoine Valeri, Frédéric Staerman, Karim Fehri, Baptiste Tisserand, Jacques Petit, Laurent Zini, Charles Deruelle, Jacques Irani, Hervé Lang, Arnauld Villers, Denis Chautard, Julien Branchereau, Romain Mathieu, Jacques Hubert, Ismaël Galliot, Franck Bruyère, Marie-Dominique Azemar, Laura Poissonnier, Fabien Saint, Laurent Salomon, Lionel Badet, and Pierre Bigot
- Subjects
medicine.medical_specialty ,medicine.anatomical_structure ,business.industry ,Urology ,Internal medicine ,Cell ,medicine ,Clinico pathological ,In patient ,business ,Gastroenterology ,End stage renal disease - Published
- 2010
- Full Text
- View/download PDF
6. 415 COMPARISON OF RENAL CELL CARCINOMAS IN END STAGE RENAL DISEASE AND GENERAL POPULATION PATIENTS
- Author
-
Franck Bruyère, Benoit Barrou, Abdel-Rahmène Azzouzi, Jean-Etienne Terrier, Jacques Petit, Laurent Zini, Yann Neuzillet, Denis Chautard, Pascal Rischmann, Julien Branchereau, Marc-Olivier Timsit, Pierre-Etienne Theveniaud, Romain Mathieu, Nicolas Brichart, Aurélien Descazeaux, S. Saint, Charles Deruelle, Jacques Irani, François Kleinclauss, Morgan Rouprêt, Nicolas Terrier, Jacques Hubert, Laurence Bastien, Fabrice Dugardin, Lucille Martin, Philippe Paparel, Michel Soulié, Hicham Elkentaoui, Arnauld Villers, J.M. Boutin, Christian Pfister, Xavier Tillou, Ismaël Galliot, Georges Karam, Jacques Tostain, Jean-Jacques Patard, J.M. Fernere, Marie-Dominique Azemar, Nathalie Rioux-Leclercq, Antoine Valeri, Sébastien Barbet, Bernard Escudier, Jean-Alexandre Long, Frédéric Staerman, Hervé Baumert, Hervé Wallerand, Thierry Lebret, Laura Poissonnier, M. Gigante, Arnaud Mejean, Laurent Salomon, Lionel Badet, Jean-Michel Correas, Pierre Bigot, Karim Fehri, Herve Lang, Benoit Feuillu, F. Sallusto, Laurent Guy, Baptiste Tisserand, and Jérôme Rigaud
- Subjects
medicine.medical_specialty ,education.field_of_study ,medicine.anatomical_structure ,business.industry ,Urology ,Population ,Cell ,medicine ,business ,education ,End stage renal disease - Published
- 2010
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.